Kiyota Naomi 清田尚臣

Researcher Number	40515037
Other IDs	https://orcid.org/0000-0001-8021-6116
Affiliation (Current)	2025: 神戸大学, 医学部附属病院, 特命准教授
Affiliation (based on the past Project Information) *help	2017 – 2024: 神戸大学, 医学部附属病院, 特命准教授 2014 – 2016: 神戸大学, 医学部附属病院, 助教
Review Section/Research Field	Principal Investigator Basic Section 56050:Otorhinolaryngology-related / Otorhinolaryngology Except Principal Investigator Basic Section 50020:Tumor diagnostics and therapeutics-related / Basic Section 56050:Otorhinolaryngology-related
Keywords	Principal Investigator 免疫チェックポイント分子 / 唾液腺癌 / 腫瘍免疫微小環境 / 遺伝子変化 / 遺伝子異常 / 遺伝子変異 / 神経内分泌悪性腫瘍 / 頭頸部がん / 免疫多重染色 / 鼻副鼻腔悪性腫瘍 … More / がん免疫微小環境 / 腫瘍遺伝子変異量 / 次世代シーケンサー / 嗅神経芽細胞腫 / 鼻副鼻腔神経内分泌腫瘍 / 遺伝子 / 免疫学 / 癌 / 腫瘍免疫 / 免疫チェックポイント阻害薬 / 頭頸部癌 / 免疫チェックポイント / 免疫染色 / 次世代シークエンサー / 唾液腺腺癌 / 唾液腺導管癌 / 分子標的薬 / 唾液腺がん … More Except Principal Investigator BCR / HLA / 免疫関連有害事象 / 免疫チェックポイント阻害薬 / irAE / 後天的要因 / 遺伝的素因 / 難聴 Less

難聴発症および重症化に関わる遺伝的素因と後天的要因の解明研究
- Principal Investigator
  
  和佐野浩一郎
- Project Period (FY)
  2024 – 2027
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Review Section
  
  Basic Section 56050:Otorhinolaryngology-related
- Research Institution
  Tokai University
Exploratory study of tumor microenviroment and biomarker for immnuene check point inhibitors in salivary gland cancerPrincipal Investigator
- Principal Investigator
  
  清田尚臣
- Project Period (FY)
  2023 – 2025
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56050:Otorhinolaryngology-related
- Research Institution
  Kobe University
B細胞を軸とした免疫チェックポイント阻害の有害事象の包括的機序解明と効果の推定
- Principal Investigator
  
  南博信
- Project Period (FY)
  2023 – 2026
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  Kobe University
Genetic alterations and expressions of immune check point molecules in sinonasal neuroendocrine carcinomaPrincipal Investigator
- Principal Investigator
  
  Kiyota Naomi
- Project Period (FY)
  2020 – 2022
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56050:Otorhinolaryngology-related
- Research Institution
  Kobe University
Genetic alterations and expressions of immune check point molecules in salivary gland cancerPrincipal Investigator
- Principal Investigator
  
  Kiyota Naomi
- Project Period (FY)
  2017 – 2019
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Otorhinolaryngology
- Research Institution
  Kobe University
Exploratory analyses of immunohistochemistry pattern and genetic alterations for salivary gland cancerPrincipal Investigator
- Principal Investigator
  
  Kiyota Naomi
- Project Period (FY)
  2014 – 2016
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Otorhinolaryngology
- Research Institution
  Kobe University

All 2023 2022 2021 2019 2018 2017 Other

All Journal Article Presentation Book

[Book] 頭頸部がん薬物療法ハンドブック2017
- Author(s)
  清田尚臣、田原信、藤井正人
- Total Pages
  232
- Publisher
  中外医学社
- ISBN
  9784498062696
- Data Source
  KAKENHI-PROJECT-17K11384
[Journal Article] Nivolumab Plus Ipilimumab Versus EXTREME Regimen as First-Line Treatment for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: The Final Results of CheckMate 6512023
- Author(s)
  Haddad R、Harrington K、Tahara M、Ferris RL、Gillison M、Fayette J、Daste A、Koralewski P、Zurawski B、Taberna M、Saba NF、Mak M、Kawecki A、Girotto G、Alvarez A、Even C、Toledo J、Guminski A、Muller-Richter U、Kiyota N、Roberts M、Khan T、Miller-Moslin K、Wei L、Argiris A
- Journal Title
  
  Journal of Clinical Oncology
  
  Volume: 41 Issue: 12 Pages: 2166-2180
- DOI
  10.1200/jco.22.00332
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-20K09731
[Journal Article] Transition of the PD?1 occupancy of nivolumab on T cells after discontinuation and response of nivolumab re?challenge2022
- Author(s)
  Nose Taku、Funakoshi Yohei、Suto Hirotaka、Nagatani Yoshiaki、Imamura Yoshinori、Toyoda Masanori、Kiyota Naomi、Minami Hironobu
- Journal Title
  
  Molecular and Clinical Oncology
  
  Volume: 16 Issue: 5
- DOI
  10.3892/mco.2022.2537
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20K07676, KAKENHI-PROJECT-20K09731
[Journal Article] Chimeric antigen receptor T-cell therapy targeting a MAGE A4 peptide and HLA-A*02:01 complex for unresectable advanced or recurrent solid cancer: protocol for a multi-institutional phase 1 clinical trial2022
- Author(s)
  Satoshi Okumura, Mikiya Ishihara, Naomi Kiyota, Kimikazu Yakushijin, Kohichi Takada, Shinichiro Kobayashi, Hiroaki Ikeda, Makoto Endo, Koji Kato, Shigehisa Kitano, Akihiko Matsumine, Yasuhiro Nagata,...Hiroshi Shiku
- Journal Title
  
  BMJ Open
  
  Volume: 12(11) Issue: 11 Pages: e065109-e065109
- DOI
  10.1136/bmjopen-2022-065109
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K06690, KAKENHI-PROJECT-21K08682, KAKENHI-PROJECT-22K08080, KAKENHI-PROJECT-22K08876, KAKENHI-PROJECT-22K19532, KAKENHI-PROJECT-21K16400, KAKENHI-PROJECT-21H02990, KAKENHI-PROJECT-20K09731, KAKENHI-PROJECT-23K24456, KAKENHI-PROJECT-23K24180
[Journal Article] Long-term Outcomes with Nivolumab as First-line Treatment in Recurrent or Metastatic Head and Neck Cancer: Subgroup Analysis of CheckMate 1412022
- Author(s)
  Gillison ML、Blumenschein G、Fayette J、Guigay J、Colevas D、Licitra L、Harrington KJ、Kasper S、Vokes EE、Even C、Worden F、Saba NF、Iglesias D、Haddad R、Rordorf T、Kiyota N、Tahara M、Jayaprakash V、Wei L、Ferris RL
- Journal Title
  
  The Oncologist
  
  Volume: 27 Issue: 2 Pages: e194-e198
- DOI
  10.1093/oncolo/oyab036
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-20K09731
[Journal Article] Systemic therapy for salivary gland malignancy: current status and future perspectives2022
- Author(s)
  Imamura Yoshinori、Kiyota Naomi、Tahara Makoto、Hanai Nobuhiro、Asakage Takahiro、Matsuura Kazuto、Ota Ichiro、Saito Yuki、Sano Daisuke、Kodaira Takeshi、Motegi Atsushi、Yasuda Koichi、Takahashi Shunji、Yokota Tomoya、Okano Susumu、Tanaka Kaoru、Onoe Takuma、Ariizumi Yosuke、Homma Akihiro
- Journal Title
  
  Japanese Journal of Clinical Oncology
  
  Volume: 52 Issue: 4 Pages: 293-302
- DOI
  10.1093/jjco/hyac008
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21K09556, KAKENHI-PROJECT-18K16834, KAKENHI-PROJECT-20K09731
[Journal Article] Immunosuppressive effects and mechanisms of three myeloid-derived suppressor cells subsets including monocytic-myeloid-derived suppressor cells, granulocytic-myeloid-derived suppressor cells, and immature-myeloid-derived suppressor cells2021
- Author(s)
  Funakoshi Yohei、Nagatani Yoshiaki、Suto Hirotaka、Imamura Yoshinori、Toyoda Masanori、Kiyota Naomi、Yamashita Kimihiro、Minami Hironobu
- Journal Title
  
  Journal of Cancer Research and Therapeutics
  
  Volume: 17 Issue: 4 Pages: 1093-1093
- DOI
  10.4103/jcrt.jcrt_1222_20
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K09731
[Journal Article] Microsatellite instability-high colorectal cancer patient-derived xenograft models for cancer immunity research2021
- Author(s)
  Funakoshi Yohei、Suto Hirotaka、Nagatani Yoshiaki、Imamura Yoshinori、Toyoda Masanori、Kiyota Naomi、Matsumoto Hisayuki、Tanaka Shinwa、Takai Ryo、Hasegawa Hiroshi、Yamashita Kimihiro、Matsuda Takeru、Kakeji Yoshihiro、Minami Hironobu
- Journal Title
  
  Journal of Cancer Research and Therapeutics
  
  Volume: 17 Issue: 6 Pages: 1358-1358
- DOI
  10.4103/jcrt.jcrt_1092_20
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K09731
[Journal Article] Roles of skull base surgery and particle radiotherapy for orbital malignant tumors involving the skull base2021
- Author(s)
  Teshima Masanori、Shinomiya Hirotaka、Kimura Hidehito、Hashikawa Kazunobu、Kiyota Naomi、Miyawaki Daisuke、Sasaki Ryohei、Kohmura Eiji、Nibu Ken‐ichi
- Journal Title
  
  Laryngoscope Investigative Otolaryngology
  
  Volume: 6 Issue: 6 Pages: 1347-1352
- DOI
  10.1002/lio2.687
- NAID
  120007179199
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K08097, KAKENHI-PROJECT-19H03603, KAKENHI-PROJECT-20K08108, KAKENHI-PROJECT-20K09731, KAKENHI-PROJECT-21K07594, KAKENHI-PROJECT-20K21576, KAKENHI-PROJECT-20KK0192
[Journal Article] Docetaxel plus cisplatin in recurrent and/or metastatic non-squamous-cell head and neck cancer: a multicenter phase II trial2021
- Author(s)
  Imamura Yoshinori、Tanaka Kaoru、Kiyota Naomi、Hayashi Hidetoshi、Ota Ichiro、Arai Akihito、Iwae Shigemichi、Minami Shujiro、Yane Katsunari、Yamazaki Tomoko、Nagatani Yoshiaki、Toyoda Masanori、Takahama Takayuki、Sakai Kazuko、Nishio Kazuto、Otsuki Naoki、Nibu Ken-ichi、Minami Hironobu
- Journal Title
  
  Medical Oncology
  
  Volume: 38 Issue: 11
- DOI
  10.1007/s12032-021-01581-z
- NAID
  120007159886
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20K09731
[Journal Article] Real-world safety and effectiveness of nivolumab for recurrent or metastatic head and neck cancer in Japan: a post-marketing surveillance2021
- Author(s)
  Tahara Makoto、Kiyota Naomi、Nibu Ken-ichi、Akamatsu Ayumi、Hoshino Tomohiro、Hayashi Ryuichi
- Journal Title
  
  International Journal of Clinical Oncology
  
  Volume: 26 Issue: 9 Pages: 1619-1627
- DOI
  10.1007/s10147-021-01949-1
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19H03804, KAKENHI-PROJECT-20K09731
[Journal Article] Nivolumab versus investigator's choice in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: Efficacy and safety in CheckMate 141 by age.2019
- Author(s)
  Saba NF, Blumenschein G Jr, Guigay J, Licitra L, Fayette J, Harrington KJ, Kiyota N, Gillison ML, Ferris RL, Jayaprakash V, Li L, Brossart P.
- Journal Title
  
  Oral Oncology
  
  Volume: 96 Pages: 7-14
- DOI
  10.1016/j.oraloncology.2019.06.017
- NAID
  120006716619
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K11384
[Journal Article] International validation of the revised European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module, the EORTC QLQ-HN43: Phase IV.2019
- Author(s)
  Singer S, Amdal CD, Hammerlid E, Tomaszewska IM, Castro Silva J, Mehanna H, Santos M, Inhestern J, Brannan C, Yarom N, Fullerton A, Pinto M, Arraras JI, Kiyota N et al.
- Journal Title
  
  Head and Neck
  
  Volume: 41 Issue: 6 Pages: 1725-1737
- DOI
  10.1002/hed.25609
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K11384
[Journal Article] A review of head and neck cancer staging system in the TNM classification of malignant tumors (eighth edition)2019
- Author(s)
  Head and Neck Cancer Study Group、Monden N、Asakage T、Kiyota N、Homma A、Matsuura K、Hanai N、Kodaira Ti、Zenda S、Fujii H、Tahara M、Yokota T、Akimoto T、Iwae S、Onitsuka T、Ogawa T、Okano S、Takahashi S、Shimizu Y、Yonezawa K、Hayashi R
- Journal Title
  
  Japanese Journal of Clinical Oncology
  
  Volume: 49 Issue: 7 Pages: 589-595
- DOI
  10.1093/jjco/hyz052
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K08190, KAKENHI-PROJECT-16K10412, KAKENHI-PROJECT-17K11384
[Journal Article] Lenvatinib for Anaplastic Thyroid Cancer2017
- Author(s)
  Tahara Makoto、Kiyota Naomi、Yamazaki Tomoko、Chayahara Naoko、Nakano Kenji、Inagaki Lina、Toda Kazuhisa、Enokida Tomohiro、Minami Hironobu、Imamura Yoshinori、Sasaki Tatsuya、Suzuki Takuya、Fujino Katsuki、Dutcus Corina E.、Takahashi Shunji
- Journal Title
  
  Frontiers in Oncology
  
  Volume: 7 Pages: 1-7
- DOI
  10.3389/fonc.2017.00025
- NAID
  120006373762
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K11384, KAKENHI-PROJECT-17K11413
[Journal Article] Japanese Clinical Practice Guideline for Head and Neck Cancer2017
- Author(s)
  Nibu Ken-ichi、Hayashi Ryuichi、Asakage Takahiro、Nagao Toshitaka、Nakatsuka Takashi
- Journal Title
  
  Auris Nasus Larynx
  
  Volume: 44 Issue: 4 Pages: 375-380
- DOI
  10.1016/j.anl.2017.02.004
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K08705, KAKENHI-PROJECT-17K11384, KAKENHI-PROJECT-15K11262
[Journal Article] Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial2017
- Author(s)
  Harrington Kevin J、Ferris Robert L、Blumenschein George、Colevas A Dimitrios、Fayette Jerome、Licitra Lisa、Kasper Stefan、Even Caroline、Vokes Everett E、Worden Francis、Saba Nabil F、Kiyota Naomi et al.
- Journal Title
  
  The Lancet Oncology
  
  Volume: 18 Issue: 8 Pages: 1104-1115
- DOI
  10.1016/s1470-2045(17)30421-7
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K11384
[Journal Article] A randomized, open-label, Phase III clinical trial of nivolumab vs. therapy of investigator’s choice in recurrent squamous cell carcinoma of the head and neck: A subanalysis of Asian patients versus the global population in checkmate 1412017
- Author(s)
  Kiyota Naomi、Hasegawa Yasuhisa、Takahashi Shunji、Yokota Tomoya、Yen Chia-Jui、Iwae Shigemichi、Shimizu Yasushi、Hong Ruey-Long、Goto Masahiro、Kang Jin-Hyoung、Sum Kenneth Li Wing、Ferris Robert L.、Gillison Maura、Namba Yoshinobu、Monga Manish、Lynch Mark、Tahara Makoto
- Journal Title
  
  Oral Oncology
  
  Volume: 73 Pages: 138-146
- DOI
  10.1016/j.oraloncology.2017.07.023
- NAID
  120006377619
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K11384
[Journal Article] The EORTC module for quality of life in patients with thyroid cancer: phase III2017
- Author(s)
  Singer Susanne、Jordan Susan、Locati Laura D、Pinto Monica、Tomaszewska Iwona M、Ara?jo Claudia、Hammerlid Eva、Vidhubala E、Husson Olga、Kiyota Naomi et al
- Journal Title
  
  Endocrine-Related Cancer
  
  Volume: 24 Issue: 4 Pages: 197-207
- DOI
  10.1530/erc-16-0530
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K11384
[Journal Article] Prognostic value of ALDH2 polymorphism for patients with oropharyngeal cancer in a Japanese population2017
- Author(s)
  Shinomiya Hirotaka、Shinomiya Hitomi、Kubo Mie、Saito Yuki、Yoshida Masafumi、Ando Mizuo、Teshima Masanori、Otsuki Naoki、Kiyota Naomi、Sasaki Ryohei、Nibu Ken-ichi
- Journal Title
  
  PLOS ONE
  
  Volume: 12 Issue: 12 Pages: e0187992-e0187992
- DOI
  10.1371/journal.pone.0187992
- NAID
  120006380399
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K11384, KAKENHI-PROJECT-16K20230, KAKENHI-PROJECT-16H05481
[Journal Article] Weekly Low‐Dose Versus Three‐Weekly High‐Dose Cisplatin for Concurrent Chemoradiation in Locoregionally Advanced Non‐Nasopharyngeal Head and Neck Cancer: A Systematic Review and Meta‐Analysis of Aggregate Data2017
- Author(s)
  Szturz Petr、Wouters Kristien、Kiyota Naomi、Tahara Makoto、Prabhash Kumar、Noronha Vanita、Castro Ana、Licitra Lisa、Adelstein David、Vermorken Jan B.
- Journal Title
  
  The Oncologist
  
  Volume: 22 Issue: 9 Pages: 1056-1066
- DOI
  10.1634/theoncologist.2017-0015
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K11384
[Journal Article] Defining Radioiodine-Refractory Differentiated Thyroid Cancer: Efficacy and Safety of Lenvatinib by Radioiodine-Refractory Criteria in the SELECT Trial2017
- Author(s)
  Kiyota Naomi、Robinson Bruce、Shah Manisha、Hoff Ana O.、Taylor Matthew H.、Li Di、Dutcus Corina E.、Lee Eun Kyung、Kim Sung-Bae、Tahara Makoto
- Journal Title
  
  Thyroid
  
  Volume: - Issue: 9 Pages: 1135-1141
- DOI
  10.1089/thy.2016.0549
- NAID
  120006377622
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K11384
[Presentation] A Phase II Trial of Nivolumab for Patients with Platinum Refractory Recurrent or Metastatic Salivary Gland Cancer2023
- Author(s)
  Nagatani Y, Kiyota N, Yamazaki T, Asada Y, Higashino M, Goto M, Satake H, Ota I, Uemura H, Yane K, Tanaka K, Onoe T, Iwae S, Hirano S, Imamura Y, Kimbara S, Nose T, Koyama T, Funakoshi Y, Minami H
- Organizer
  Am Soc Clin Oncol
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-23K27457
[Presentation] Relationship between tumor burden to growth rate and treatment outcomes of nivolumab for patients with head and neck squamous carcinoma.2019
- Author(s)
  Chiaki Suzuki, Naomi Kiyota, Yoshinori Imamura, Junpei Rikitake, Satoshi Sai, Taiji Koyama, Yasuko Hyogo, Yoshiaki Nagatani, Yohei Funakoshi, Masanori Toyoda, Naoki Otsuki, Ken-ichi Nibu, Hironobu Minami
- Organizer
  the 2019 ASCO-SITC, Clinical Immuno-Oncology Symposium
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K11384
[Presentation] 頭頸部腫瘍　Up to Date2019
- Author(s)
  清田尚臣
- Organizer
  第57回日本癌治療学会学術集会
- Invited
- Data Source
  KAKENHI-PROJECT-17K11384
[Presentation] Docetaxel plus Cisplatin in Recurrent and/or Metastatic Non-squamous Cell Carcinoma of Head and Neck: a Phase II Trial2018
- Author(s)
  Yoshinori Imamura*, Naomi Kiyota*, Kaoru Tanaka, Hidetoshi Hayashi, Ichiro Ota, Shigeru Hirano, Shigemichi Iwae, Shujiro Minami, Katsunari Yane, Tomoko Yamazaki, Yoshiaki Nagatani, Masanori Toyoda, Naoki Otuski, Ken-ichi Nibu, and Hironobu Minami
- Organizer
  第16回日本臨床腫瘍学会
- Data Source
  KAKENHI-PROJECT-17K11384
[Presentation] 口腔癌に対する免疫チェックポイント阻害薬の適正使用と腫瘍内科医との診療連携2017
- Author(s)
  清田尚臣
- Organizer
  第36回日本口腔腫瘍学会総会学術大会
- Invited
- Data Source
  KAKENHI-PROJECT-17K11384
[Presentation] 頭頸部がんに対する分子標的薬及び免疫チェックポイント阻害薬の役割2017
- Author(s)
  清田尚臣
- Organizer
  第69回日本気管食道科学会総会
- Invited
- Data Source
  KAKENHI-PROJECT-17K11384
[Presentation] 腫瘍内科医からみた頭頸部がん臨床試験におけるIMRTの重要性と課題2017
- Author(s)
  清田尚臣
- Organizer
  第41回日本頭頸部癌学会
- Invited
- Data Source
  KAKENHI-PROJECT-17K11384
[Presentation] Molecular targeted treatment for thyroid cancer2017
- Author(s)
  Kiyota Naomi
- Organizer
  2nd Congress of Asia-Pacific Society of Thyroid Surgery
- Invited / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K11384
[Presentation] 転移再発甲状腺がんに対する薬物療法2017
- Author(s)
  清田尚臣
- Organizer
  日本内分泌外科学会2017
- Invited
- Data Source
  KAKENHI-PROJECT-17K11384
[Presentation] 頭頸部がんに対する免疫チェックポイント阻害薬2017
- Author(s)
  清田尚臣
- Organizer
  日本頭頸部癌学会主催第8回教育セミナー
- Invited
- Data Source
  KAKENHI-PROJECT-17K11384
[Presentation] 頭頸部がんに対する免疫チェックポイント阻害薬の適正使用2017
- Author(s)
  清田尚臣
- Organizer
  第31回日本耳鼻咽喉科学会専門医講習会
- Invited
- Data Source
  KAKENHI-PROJECT-17K11384
[Presentation] Comparative analysis of the clinicopathological features of salivary duct carcinoma and salivary gland adenocarcinoma, not otherwise specified
- Author(s)
  Naomi Kiyota
- Organizer
  第12回日本臨床腫瘍学会学術集会
- Place of Presentation
  福岡
- Year and Date
  2014-07-17 – 2014-07-19
- Data Source
  KAKENHI-PROJECT-26462605

1. Otsuki Naoki (40343264)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
2. ITOH Tomoo (20301880)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
3. NISHIO Kazuto (10208134)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
4. SAKAI Kazuko (20580559)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
5. 和佐野浩一郎 (40528866)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
6. 古平毅 (80303626)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
7. 内田育恵 (80313998)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
8. 吉田忠雄 (90567017)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
9. 南博信 (60450574)

# of Collaborated Projects: 1 results

# of Collaborated Products: 2 results
10. 船越洋平 (50566966)

# of Collaborated Projects: 1 results

# of Collaborated Products: 2 results
11. Hirai Chihoko

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
12. NAGATA Yasuhiro

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
13. MIYAWAKI Daisuke

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
14. 佐々木良平

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
15. 長尾俊孝

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
16. 齊藤祐毅

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
17. 舟生健一

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
18. 秋元哲夫

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Kiyota Naomi 清田 尚臣

Research Projects

Research Products

Co-Researchers

難聴発症および重症化に関わる遺伝的素因と後天的要因の解明研究

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Exploratory study of tumor microenviroment and biomarker for immnuene check point inhibitors in salivary gland cancerPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

B細胞を軸とした免疫チェックポイント阻害の有害事象の包括的機序解明と効果の推定

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Genetic alterations and expressions of immune check point molecules in sinonasal neuroendocrine carcinomaPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Genetic alterations and expressions of immune check point molecules in salivary gland cancerPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Exploratory analyses of immunohistochemistry pattern and genetic alterations for salivary gland cancerPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Book] 頭頸部がん薬物療法ハンドブック2017

Author(s)

Total Pages

Publisher

ISBN

Data Source

[Journal Article] Nivolumab Plus Ipilimumab Versus EXTREME Regimen as First-Line Treatment for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: The Final Results of CheckMate 6512023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Transition of the PD?1 occupancy of nivolumab on T cells after discontinuation and response of nivolumab re?challenge2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Chimeric antigen receptor T-cell therapy targeting a MAGE A4 peptide and HLA-A*02:01 complex for unresectable advanced or recurrent solid cancer: protocol for a multi-institutional phase 1 clinical trial2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Long-term Outcomes with Nivolumab as First-line Treatment in Recurrent or Metastatic Head and Neck Cancer: Subgroup Analysis of CheckMate 1412022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Systemic therapy for salivary gland malignancy: current status and future perspectives2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Immunosuppressive effects and mechanisms of three myeloid-derived suppressor cells subsets including monocytic-myeloid-derived suppressor cells, granulocytic-myeloid-derived suppressor cells, and immature-myeloid-derived suppressor cells2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Microsatellite instability-high colorectal cancer patient-derived xenograft models for cancer immunity research2021

Author(s)

Journal Title

DOI

Kiyota Naomi 清田尚臣